Welcome Guest
Home > Clinical Genitourinary Cancer > Volume 4 |  Issue 2

Table of Contents

Volume 4 |  Issue 2

Publication Date: September 2005
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Meeting Highlights
Page Number of this Article in the Print Version
73-78		 Highlights from: the 5th Annual International Congress on Monoclonal Antibodies in Cancer; Quebec City, Canada; August 2005; the 5th International Prostate Cancer Congress; Rio Grande, Puerto Rico; July 2005; the 41st Annual Meeting of the American Society of Clinical Oncology; Orlando, Florida; May 2005
G. Kesava Reddy, Preeta Tyagi, Eric Nadler, Vinay K. Jain
  • Abstract
  • No Access
  • Add to Cart
Researches in Brief
Page Number of this Article in the Print Version
80-82		 Potential Role of Inhibiting the Vascular Endothelial Growth Factor Pathway in Advanced Prostate Cancer
Preeta Tyagi, Eric Nadler, Arif Hussain
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
83-85		 Early Clinical Data and Potential Clinical Utility of Novel Histone Deacetylase Inhibitors in Prostate Cancer
G. Kesava Reddy, Eric Nadler, Arif Hussain
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
86-90		 Second-Line Chemotherapy for Prostate Cancer: Patient Characteristics and Survival
Kathleen W. Beekman, Mark T. Fleming, Howard I. Scher, Susan F. Slovin, Nicole M. Ishill, Glenn Heller, W. Kevin Kelly
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
91-99		 Safety and Tolerability of PCK3145, a Synthetic Peptide Derived from Prostate Secretory Protein 94 (PSP94) in Metastatic Hormone-Refractory Prostate Cancer
Robert E. Hawkins, Luc Daigneault, Richard Cowan, Richard Griffiths, Chandra Panchal, Anne Armstrong, Jackie Fenemore, Alan Irvine, Kasia Sereda, Hélène Dulude
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
100-108		 A Measure of Health-Related Quality of Life Among Patients with Localized Prostate Cancer: Results from Ongoing Scale Development
Christie A. Befort, Michael J. Zelefsky, Peter T. Scardino, Evelinn Borrayo, R. Brian Giesler, Michael W. Kattan
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
109-112		 Quantitative Computed Tomography Perfusion of Prostate Cancer: Correlation with Whole-Mount Pathology
Elizabeth P. Ives, Melissa A. Burke, Pamela R. Edmonds, Leonard G. Gomella, Ethan J. Halpern
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
113-117		 Prior Estrogen Therapy as a Predictor of Response to Subsequent Estramustine-Based Chemotherapy in Patients with Androgen-Independent Prostate Cancer
Jorge A. Garcia, Vivian Weinberg, Eric J. Small
  • Abstract
  • No Access
  • Add to Cart
Translational Medicine
Page Number of this Article in the Print Version
118-123		 Prostate-Specific Membrane Antigen Vaccines: Naked DNA and Protein Approaches
Susan F. Slovin
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
124-129		 Molecular Effects of the Isoflavonoid Genistein in Prostate Cancer
Jasmin Bektic, Roman Guggenberger, Iris E. Eder, Alexandre E. Pelzer, Andreas P. Berger, Georg Bartsch, Helmut Klocker
  • Abstract
  • No Access
  • Add to Cart
Brief Communication
Page Number of this Article in the Print Version
130-133		 Recent Trends in Surgical Treatment of Localized Prostate Cancer
Brian A. Link, Daniel J. Culkin
  • Abstract
  • No Access
  • Add to Cart
Case Report
Page Number of this Article in the Print Version
134-137		 Orbital Metastasis from Prostate Cancer: An Atypical Case of Neuroendocrine Dedifferentiation During Progression from Hormone-Sensitive to Refractory Stage
Suneetha Challagundla, Murat Gokden, Sanjaya Viswamitra, Manish Kohli
  • Abstract
  • No Access
  • Add to Cart
Current Trial
Page Number of this Article in the Print Version
138-141		 A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
Elisabeth I. Heath, Melvin Gaskins, Henry C. Pitot, Roberto Pili, Winston Tan, Robert Marschke, Glenn Liu, David Hillman, Fazlul Sarkar, Shijie Sheng, Charles Erlichman, Percy Ivy
  • Abstract
  • No Access
  • Add to Cart